Ductal carcinoma in situ

Marica Skaar; Linnea Langhans; Birgitte Mertz; Niels Kroman

Ductal carcinoma in situ

Translated title of the contribution: Ductal carcinoma in situ

Marica Skaar, Linnea Langhans, Birgitte Mertz, Niels Kroman

Breast Surgery

1 Citation (Scopus)

Abstract

Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

Translated title of the contribution	Ductal carcinoma in situ
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	180
Issue number	38
ISSN	0041-5782
Publication status	Published - 17 Sept 2018

Cite this

@article{ea410fa0ddbf40a9ad6cabae402776e7,

title = "Ductal carcinoma in situ",

abstract = "Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.",

author = "Marica Skaar and Linnea Langhans and Birgitte Mertz and Niels Kroman",

year = "2018",

month = sep,

day = "17",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "38",

}

TY - JOUR

T1 - Ductal carcinoma in situ

AU - Skaar, Marica

AU - Langhans, Linnea

AU - Mertz, Birgitte

AU - Kroman, Niels

PY - 2018/9/17

Y1 - 2018/9/17

N2 - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

AB - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

M3 - Tidsskriftartikel

C2 - 30259839

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 38

ER -

Ductal carcinoma in situ

Abstract

Fingerprint

Cite this